 t-PA PAI vascular occlusion upper limb patients Raynaud phenomenon Tissue plasminogen activator t-PA inhibitor PAI venous blood drawn venous occlusion bvo avo patients Raynaud phenomenon RP primary RP PRP suspected secondary RP SSRP definite collagen disease secondary RP SRP significant differences PAI values PRP controls SSRP SRP PAI activity controls PRP significant t-PA antigen elevation avo groups addition PAI activated protein PC PC antigen PC activity avo bvo PC Ag unchanged groups PC activity controls SRP SSRP authors interference anticardiolipin antibodies ACA lupus-like anticoagulant LAC PC system collagen disease-associated RP Specific IgG ACA patient SRP conclusion endothelial derangement t-PA release PAI SSRP SRP patients reduced PC activity latter groups due PAI influence ACA/LAC